Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017636 (
glioblastoma
)
18,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The HIPPI (HIP-1 protein interactor) protein is a multifunctional protein that is involved in the regulation of apoptosis. The interaction partners of HIPPI include HIP-1 (Huntingtin-interacting protein-1), Apoptin, Homer1c, Rybp/DEDAF, and BAR (bifunctional apoptosis regulator). In search for other binding partners of HIPPI, we performed a yeast two hybrid screen and identified
BLOC1S2
(Biogenesis of lysosome-related organelles complex-1 subunit 2) as a novel HIPPI-interacting protein. In co-immunoprecipitation assays,
BLOC1S2
specifically associates with HIPPI, but not with HIP-1. To study the expression of
BLOC1S2
on the protein level, we generated a mouse monoclonal antibody specific for
BLOC1S2
and a multiple tissue array comprising 70 normal and cancer tissue samples of diverse origin.
BLOC1S2
protein is widely expressed in normal tissue as well as in malignant tumors with a tendency towards lower expression levels in certain subtypes of tumors. On the subcellular level,
BLOC1S2
is expressed in an organellar-like pattern and co-localizes with mitochondria. Over-expression of
BLOC1S2
in the presence or absence of HIPPI does not induce apoptosis. However,
BLOC1S2
and HIPPI sensitize NCH89
glioblastoma
cells to the pro-apoptotic actions of staurosporine and the death ligand TRAIL by enhancing caspase activation, cytochrome c release, and disruption of the mitochondrial membrane potential. Given its interaction with HIPPI and its pro-apoptotic activity,
BLOC1S2
might play an important functional role in cancer and neurodegenerative diseases.
...
PMID:BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis. 1818 4